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ABSTRACT 
Techniques are described for the coating of sorbents to be 
used in an artificial liver support system based on mixed sor- 
bent bed hemoperfusion. Activated charcoal has been coated 
with cellulose acetate (CA) by solvent evaporation. With Am- 
berlite XAD-4, the Wurster technique was used for coating 
with CA. XAD-4 has also been coated with a synthetic poly- 
electrolyte with anticoagulant activity by adsorption and fix- 
ation by gamma radiation-induced crosslinking. Activated 
charcoal, XAD-4, and a cation exchange resin, all in powdered 
form, were encapsulated in agarose gel beads. Adsorption 
characteristics onto the sorbents are described. The results 
are in agreement with a theoretical model presented. In gen- 
eral, adsorption onto XAD-4 is limited by film diffusion. With 
activated charcoal, pore diffusion limitation is generally ob- 
served. Blood compatibility is improved by coating. 
Key words: coatings, sorbents, adsorption kinetics theory and 
practice, blood compatibility 
INTRODUCTION 
Treatment of severe acute and chronic liver failure 
remains a serious medical problem. The encephalop- 
athy and coma associated with fulminant hepatic fail- 
ure is generally attributed to  the accumulation of 
water-soluble as well as protein-bound and fat-soluble 
toxic compounds in  the systemic circulation.’ Al- 
though the exact identity of the etiological factors is 
still unknown, several agents such as ammonia, fatty 
acids, mercaptans, phenols, biogenic amines, some 
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amino acids, and probably middle molecules are re- 
ported to be involved.’ In addition, synergistic effects 
are observed between several of the toxins listed 
above.’ Removal of these toxins from the blood seems 
to be a rational approach. Hemodialysis, however, 
does not improve s ~ r v i v a l . ~  This is likely due to pro- 
tein binding and water insolubility of some of the tox- 
ins involved. Hemoperfusion through coated activated 
charcoal improves the survival of rats with grade I1 
hepatic coma;4 however, the effect in clinical studies 
has yet to  be p r ~ v e n . ~  Activated charcoal is very ef- 
fective in the removal of water-soluble compounds, 
but is less suited for protein-bound substances.6 Both 
neutral and charged resins are more appr~pr ia te .~  
Therefore, hemoperfusion through a combination of 
activated charcoal, neutral (XAD) and cation ex- 
change resins at  an early stage of the disease may be 
worthwhile to  t ry  in the treatment of acute liver fail- 
ure in The application of this kind of treat- 
ment is hampered by serious blood compatibility prob- 
lems. Notably, resins show very severe thrombocyte 
losses,’ and, especially with liver patients, this cannot 
be accepted since these patients already have an in- 
creased bleeding tendency. In order to  reduce the loss 
of platelets, coating of the sorbents with thin, perme- 
able, blood-compatible membranes is required. 
Tijssen et al.’ have described the coating of char- 
coal with an ultrathin membrane of cellulose acetate 
(CA), making use of a simple solvent evaporation 
technique. In vivo platelet losses were of the order of 
15% after four hours of hemoperfusion of intoxicated 
patients. This technique was adopted in this work for 
the coating of activated charcoal with CA. The pro- 
cedure failed in the coating of resins because of strong 
agglomeration of resin particles. Avoiding this, Am- 
berlite XAD-4 has successfully been coated with CA 
by means of the Wurster technique.” In this fluid-bed 
technique, partial drying of resin particles occurs. For 
that reason, only neutral resins could be coated, since 
ion exchange resins show too strong an expansion 
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upon rewetting, which causes the coating membrane 
to  rupture. Furthermore, XAD-4 has been coated with 
a synthetic polyelectrolyte (PLE), which has antico- 
agulant activity, by adsorption followed by fixation of 
the adsorbed PLE by gamma radiation-induced cross- 
linking.” Since no adsorption of PLE takes place onto 
cation exchange resin, this procedure proved to be not 
applicable for this sorbent, while a PLE coating ap- 
plied to activated charcoal appeared to be unstable. 
Brunner et a1.I’ have described a method for the 
encapsulation of sorbents in agarose gel. Using this 
technique, activated charcoal, Amberlite XAD-4 and 
a cation exchange resin, all in powdered form, were 
encapsulated. The mechanical strength of these cap- 
sules is not very high and sterilization is difficult 
since the capsules have a melting point of 90°C and 
are not resistant to gamma radiation. To overcome 
these problems, a crosslinking procedure has been de- 
veloped by the reaction with 1,3-dichloro-2-propanol 
at strong alkaline conditions. After crosslinking, the 
compression strength is increased by a factor of 4, 
while the capsules can be autoclaved at 122°C for sev- 
eral hours without changes in properties.” 
A logical consequence of these procedures is t o  
investigate t o  what extent these coatings affect the 
adsorption characteristics of the sorbents. We have, 
therefore, studied this influence and the effects of sor- 
bent particle size and of hydrodynamic conditions on 
the adsorption kinetics. This has been related to a the- 
oretical model. The in vitro blood compatibility with 
regard to thrombocyte losses, using both citrated and 
heparinized fresh human blood, was examined. 
THEORETICAL CONSIDERATIONS 
Adsorption is a complicated process in which mole- 
cules are transported from the well-mixed bulk of the 
solution across a thin, stagnant, liquid film envelop- 
ing every particle, through the pore system, to the in- 
terior of the sorbent. Depending on concentration, dif- 
fusion constants of the adsorbate, and hydrodynamic 
conditions, the rate of adsorption can either be limited 
by diffusion through the pores of the sorbent or by 
diffusional transport across the stagnant film. For 
both extremes, simple approximative relations can be 
derived, expressing the concentration in the bulk of 
the solution as a function of the recirculation time. 
The derivations were based on those of Boyd et al.,13 
but were corrected for a recirculation system with de- 
creasing concentration. 
Film Diffusion Limitation 
When a linear concentration gradient across the 
film and equilibrium at the surface of the sorbent are 
- 
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assumed for all times of contact, combination of the 
mass balance and the first law of Fick leads to  Equa- 
tion l: 
(1) (C, - C,)/(Co - C,) = exp(-RSt) 
In this relation the rate constant is 
R = 3D/r6cw (2) 
and S = C,/C, = ma/pV + 1 (3) 
The distribution coefficient a, defined as a = 
cS,or/C~q, and the diffusion constant D are assumed to 
be independent of the concentration. When the con- 
centration at infinite time, CJC,, approaches zero, 
ma/pV >> 1, and Eq. 1 reduces to  Eq. 4. 
C,/Co = exp(-R‘t) (4) 
( 5 )  In this relation, R’ = 3mD/prGV 
Pore Diffusion Limitation 
Equation 6 is derived by following the same rea- 
soning and combining the mass balance with the sec- 
ond law of Fick. 
C,/C’ = 1 - Kt”’ (6) 
This ~- ~. represents an alternative expression of the well- 
known “parabolic” diffusion law in which the pore dif- 
fusion rate constant K is defined as: 
K = 6ma(D/n)”*/pVr (7) 
The symbols employed are: 
C = concentration mg/L 
D = diffusion constant m2/min 
min- ‘ I *  K = pore diffusion rate constant 
m = mass of sorbent kg 
r = radius of sorbent particles m 
R = film diffusion rate constant min-’ 
t = recirculation time min 
V = recirculating volume m5 
a = distribution coefficient - 
6 = thickness of the film m 
p = density of the sorbent 
superscripts: liq = liquid, sor = sorbent 
kg/m3 
MATERIALS AND METHODS 
Materials 
The sorbents employed were: Norit RBX-1, ex- 
truded granular activated charcoal, obtained from 
Norit (Amersfoort, Netherlands); Amberlite XAD-4, 
neutral polystyrene-based resin (0.3-1.0 mm), ob- 
tained from Serva (Heidelberg, Germany); Imac C-12, 
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strong acidic cation exchange resin (0.25-0.85 mm), 
donated by Akzo-Chemie (Amsterdam, Netherlands). 
The coating materials employed were: cellulose 
acetate (40.1% acetyl) with an average molecular 
weight of 53,000 daltons, obtained from Fabelta (Tub- 
ize, Belgium, Type TV-20); polyelectrolyte synthesized 
from cis-1,4-p0lyisoprene;'~ agarose powder (Type C) 
obtained from Pharmacia Fine Chemicals (Uppsala, 
Sweden), crosslinked after encapsulation with 1,3- 
dichloro-2-propanol (Aldrich, Beerse, Belgium). 
Coating Techniques 
Cellulose Acetate Coating 
Activated charcoal was coated with CA (4 gm CAI 
kg charcoal) by the solvent evaporation technique, 
using a solution of CA in acetone (4 gm/L) as de- 
scribed by Ti j~sen. '~  Amberlite XAD-4 was coated in 
a laboratory-scale Wurster coating device (Uni-Glatt, 
Haltingen, Germany). A solution in acetone (7 gm/L) 
was atomized onto the fluidized particles by a pneu- 
matic nozzle to a total amount of 6 gm CA/kg XAD- 
4. Air-dried particles were rewetted in ethanol, which 
was replaced by water." 
Pol.yelectrolyte Coating 
A net weight of 250 gm XAD-4 was placed in 150 
ml of PLE solution (25 mg/ml) in phosphate-buffered 
saline (pH = 7.4). The adsorbed PLE (3 mg/gm) was 
crosslinked by means of gamma irradiation with a to- 
tal dose of 4 Mrads as described previously." 
Encapsulation in Agarose Gel 
The method used was based on the procedure de- 
scribed by Brunner et al." with the following modi- 
fications. All sorbents were ground in a vibrating disc 
mill (Siebtechnik, Muhlheim/Rhur, Germany). Frac- 
tions able to pass a 140-mesh sieve were used for en- 
capsulation. A suspension of 4% w/w of agarose pow- 
der was used with an amount of sorbent to yield a wet 
sorbent weight content of 33%. The fractions with a 
diameter from 0.85 to 3.35 mm were used for further 
experiments, unless otherwise indicated. 
These capsules were crosslinked by reaction with 
1,3-dichloro-2-propanol in a twofold molar excess with 
regard to  agarose hydroxyl groups and an equimolar 
amount of NaOH with regard to dichloropropanol 
(DCP) at  a concentration of 0.4 mol/L. A typical for- 
mulation was: agarose capsules, 200 gm; alkaline so- 
lution, 600 ml, 0.4 mol/L; DCP, 9 ml. The reaction 
was allowed to  proceed for four hours at  50°C. A de- 
tailed description and the optimization will be pre- 
sented elsewhere." After crosslinking, the capsules 
were washed with water and stored wet. 
Adsorption Kinetics 
The rates of adsorption of test compounds with a 
molecular weight from 94 to 5200 daltons onto coated 
and uncoated sorbents were measured in a recirculat- 
ing system at 37°C. In all cases, 1 liter of solution in 
phosphate-buffered saline (pH = 7.4,0.02 mol KH,PO,/ 
L, 9 gm NaCl/L) was recirculated at a flow rate of 34 
ml/min through a small column (17 mm in diameter) 
containing 6.25 gm of sorbent. When agarose capsules 
were tested, either the sorbent volume/recirculating 
volume ratio or the sorbent weight/recirculating vol- 
ume ratio was kept equal to the ratio for the native 
sorbent by adjusting the recirculating volume. 
Phenol (C, = 150 mg/L); creatinine (150 mg/L); 
methyl orange (50 mg/L); BSP (100 mg/L); vitamin 
B,, (50 mg/L); and inulin (100 mg/L) were used as 
test compounds. Samples were drawn over a total time 
of 180 minutes at 30-minute intervals. The concentra- 
tions of phenol, methyl orange, BSP (after adjusting 
the pH to 121, and vitamin B,, were determined pho- 
tospectrometrically at wavelengths of 271 nm, 467 
nm, 581 nm, and 363 nm, respectively. With creati- 
nine the extinction was read at 490 nm after color re- 
action with picric acid, while inulin was determined 
at 635 nm after color reaction with diphenylamine and 
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FIG. 1. Film diffusion-limited adsorption of methyl orange onto 
activated charcoal. Native and CA-coated granular charcoal. Pow- 
dered charcoal encapsulated in agarose, equal volume (ag(v)) and 
equal weight (ag(w)). C,/C, on a logarithmic scale versus time. 
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FIG. 2. Film diffusion-limited adsorption of BSP onto XAD-4. 
Native and CA- and PLE-coated bead-form resin. Powdered resin 
encapsulated in agarose, equal volume (ag(v)) and equal weight 
(ag(w)). (C, - C,)/(C, - C,) on a logarithmic scale versus time. 
hydrochloric acid hydr01ysis.l~ The influence of flow 
rate and particle size on the adsorption kinetics was 
studied with methyl orange and vitamin B,, onto ac- 
tivated charcoal encapsulated in agarose, using flow 
rates of 10,34, and 70 ml/min and capsule diameters 
of 5.6-3.35 mm; 3.35-2.0 mm; 3.35-0.85 mm, and 
2.0-0.85 mm. 
Blood Compatibility 
In vitro thrombocyte losses caused by the various 
coated and uncoated sorbents were measured in the 
recirculation system described by Chamuleau et a1.’ 
Fresh human blood (250 ml) was recirculated through 
100 gm of sorbent at  a flow rate of 100 ml/min at a 
temperature of 37°C. The system was primed with 
physiological saline prior to  use. From a solution of 
disodium citrate (3%) and glucose (2.5%), 65 ml were 
added to 435 ml of blood. The citrated blood was di- 
vided into two equal portions for simultaneous exper- 
iments. When heparin was used as the anticoagulant, 
the system was primed with 2500 U in 250 ml of phys- 
. . .  
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FIG. 3. Pore diffusion-limited adsorption of vitamin BIZ onto ac- 
tivated charcoal. C,/C,  versus time on a square root scale. 
iological saline for 30 minutes. In the blood a dose of 
5000 U/L was employed. Empty wlumns were used 
for blank experiments. 
RESULTS 
Adsorption Kinetics 
The adsorption kinetics of methyl orange onto 
coated and uncoated activated charcoal are presented 
in Figure 1. Since a linear relation is obtained be- 
tween ln(C,/C,) and time, the rate of adsorption is 
limited by diffusional transport across the liquid 
boundary film. The concentration at  infinite time ap- 
proaches zero, thus the adsorption process can be char- 
acterized completely by the rate constant R’, which is 
the slope of the graph as indicated in Figure 1. 
The same mechanism but with a concentration at 
infinite time CJC, of 0.145 is observed for the ad- 
sorption of BSP onto coated and uncoated Amberlite 
XAD-4, as shown in Figure 2. A linear relation is ob- 
TABLE I
CHARACTERISTICS OF ADSORPTION ONTO AMBERLITE XAD-4 
Phenol Methyl Orange BSP Vitamin B,, Inulin 
Coating Q3h R c,/co Q3h R’ K Q3h R c=/co Q3h R c=/co Q3h R c=/co 
native 52.9 22.6 ,647 48.4 19.2 67.3 1.25 ,145 36.3 1.69 ,155 18.4 4.06 ,713 
CA 52.9 22.4 ,647 47.9 17.6 65.4 1.17 ,145 28.0 .93 ,155 7.7 1.24 .713 
PLE 52.9 21.6 ,647 47.5 16.6 49.2 .70 ,145 28.6 .97 ,155 7.0 1.10 ,713 
ag(v) 23.3 21.4 .845 18.3 27.9 33.7 1.15 ,326 11.1 .88 .355 3.4 1.67 ,881 
52.9 21.4 ,647 50.0 83.7 65.1 1.15 ,145 27.0 .88 ,155 9.9 1.67 ,713 ag(w) 
In this table, the total amount adsorbed after three hours (Q3,,) is expressed in mg. The rate constants R and R’ are expressed in min-’. 
The rate constant K is expressed in 
Native and CA- and PLE-coated bead-form XAD-4. Powdered XAD-4 encapsulated in  agarose compared on the base of equal volume (ag(v)) 
and on the base of equal weight (ag(w)). 
- 
mid’*.  
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TABLE I1 
CHARACTERISTICS OF ADSORPTION ONTO ACTIVATED CHARCOAL 
Methyl 
C r e a t i n i n e Orange BSP Vitamin B,, Inulin 
Coating Q3h K R' Q3h R' Q3h K R c=/co Q3h K Q3h K R CJCO 
native 132.1 65.7 47.8 17.4 39.7 29.8 11.1 16.3 19.1 14.2 
CA 119.1 59.7 41.7 9.9 24.3 18.8 5.9 8.9 10.0 7.5 
5.3 8.3 8.4 3.84 ,849 adv) 24.4 0.96 38.3 7.9 34.0 3.71 530 
ag(w 1 74.2 3.79 50.0 31.3 73.9 3.71 ,222 22.1 32.8 28.7 3.84 ,588 
In this table, the total amount adsorbed after three hours (Q3h) is expressed in mg. "he rate constants R' and R are expressed in  min-'. 
The rate constant K is expressed in 
Native and CA-coated granular activated charcoal. Powdered charcoal encapsulated in agarose, compared on the base of equal volume (ag(v)) 
and equal weight (ag(w)). 
min-'". 
tained between ln{(C, - C,) / (C,  - C J }  and time. In 
this case the adsorption rate is characterized com- 
pletely by the constants R and C,/C,  = S. The slope 
in the graph refers to the product of R and S, as in- 
dicated in Figure 2. 
A completely different situation is met in the ad- 
sorption of vitamin B,, onto activated charcoal (Fig. 
3). A linear relation is observed between the concen- 
tration C, /C ,  and the square root of time. This indi- 
cates that the rate of adsorption is limited by diffu- 
sional transport through the pores of the sorbent. The 
adsorption kinetics are completely characterized by 
the rate constant K ,  which is the slope of the graph 
as indicated in Figure 3. 
All data obtained are presented in Table I for the 
adsorption onto Amberlite XAD-4, and in Table I1 for 
the adsorption onto activated charcoal. The appropri- 
ate rate constants R' ,  R ,  and CJC,, and K are pre- 
sented. In all cases the 99% confidence limit for the 
rate constants is of the order of 5%. All measurements 
1.0 1 
0.8 1 
\ CA 
PLE 
0.1 0.2 0.5 1 2 5 
molecular weight (kiloDalton) 
FIG. 4. Effect of coating on the relative adsorbed amounts after 
three hours onto Amberlite XAD-4 as a function of molecular 
weight. Native and CA- and PLE-coated bead-form resin; powdered 
resin encapsulated in agarose. 
showed correlation coefficients of 0.998 or better. In 
addition the total amount of test compound adsorbed 
within three hours (Q,,) is presented. No adsorption 
was found of creatinine onto Amberlite XAD-4. 
The permeability of the coatings for the various 
test compounds, expressed as the ratio of the total 
amount adsorbed after three hours over the total 
amount adsorbed onto the uncoated native sorbent in 
the same time (Q3h/Q3h,native) as a function of molec- 
ular weight, is presented in Figure 4 for the adsorp- 
tion onto XAD-4. A sudden decrease is observed when 
the molecular weight is over 1000 daltons. No large 
deviations are observed for the various coatings. Only 
agarose capsules, compared on the basis of volume 
(ag(v)), show a decreased adsorption. 
Figure 5 shows the same relation for adsorption 
onto activated charcoal. The decline in &3h/&3h,nati,.e 
2.0 
1.5 
1.0 
u 
m 
z 
.- - 
r < 0.5 
U 
0 
I 
.i 
0.1 0.2 0.5 1 2 5 
molecular weight (kiloDalton] 
FIG. 5. Effect of coating on the relative adsorbed amounts after 
three hours onto activated charcoal as a function of molecular 
weight. Native and CA-coated granular charcoal and powdered 
charcoal encapsulated in agarose. 
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FIG. 6. Effect of capsule radius on the film diffusion rate con- 
stant R '  of methyl orange (0) and on the pore diffusion rate con- 
stant K of vitamin B,, (0) onto activated charcoal encapsulated in 
agarose. 
for the CA coating occurs at a lower molecular weight, 
compared to  CA-coated XAD-4. Another striking ob- 
servation is that agarose capsules, compared on the 
base of volume, show an adsorption comparable to  CA- 
coated charcoal. When equal charcoal weights are 
compared (ag(w)), an increase in adsorption is ob- 
served. 
The effect of agarose capsule size on the adsorp- 
tion rate onto activated charcoal for a typical film dif- 
fusion-limited compound (methyl orange) and a typ- 
ical pore diffusion-limited compound (vitamin BIZ) is 
shown in Figure 6. Both the film diffusion rate con- 
stant R' and the pore diffusion rate constant K appear 
to  be inversely proportional to  the mean capsule ra- 
dius. The effect of flow rate, using the same com- 
3 0  
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E 2 0  
m 
I 
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1 0  
- Ki 
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a- 
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I 
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f l o w  r a t e  mI/min 
FIG. 7. Effect of flow rate on the film diffusion rate constant R' 
of methyl orange (0) and of the pore diffusion rate constant K of 
vitamin B,, (0) onto activated charcoal encapsulated in agarose. 
pounds, is presented in Figure 7. The film diffusion 
rate constant R' appears to be proportional to the flow 
rate. On the contrary, no significant influence of flow 
rate can be observed on the pore diffusion rate con- 
stant K. 
Blood Compatibility 
The in vitro thrombocyte losses caused by the 
various coated and uncoated sorbents are presented 
in Table 111. The very preliminary results for most of 
the agarose capsules are presented only for the sake 
of completeness. It is obvious that coating has a ben- 
eficial effect on blood compatibility. In all cases the 
platelet losses with heparinized blood are much more 
pronounced than with citrate as anticoagulant. 
TABLE I11 
IN VITRO BLOOD COMPATIBILITY OF SORBENTS 
Citrated Blood Heparinized Blood 
Sorbent n 60 min 120 min 180 rnin n 60 min 120 min 180 rnin 
85 (9) 85 (15) 8 
46 (17) 49 (19) 6 
71 (15) 8 
8) 48 (17) 
blank 5 
charcoal native 4 
CA 4 81 (15) 73 (12) 
agarose 2 87 (1) 90 (1) 86 (2) 1 
XAD-4 native 4 15 (12) 19 (16) 20 (15) 4 
CA 4 70 (16) 63 (18) 56 (19) 5 
PLE 8 81 (12) 73 (12) 72 (16) 7 
agarose 1 64 70 58 1 
Imac C-12 native 1 
agar o s e 4 
Percentage of initial count after 6G, 120, 180 minutes of recirculation time; mean (SD) 
Citrated and heparinized blood. 
87 (5) 
29 (13) 
48 (8) 
61 
15 (8) 
58 (19) 
25 (13) 
57 
41 
57 (16) 
78 (11) 
25 (12) 
42 (17) 
52 
2 1  (10) 
49 (18) 
27 (11) 
38 
34 
35 (20) 
70 (15) 
20 (13) 
39 (17) 
46 
18 (13) 
35 (16) 
27 (12) 
23 
27 
27 (9) 
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DISCUSSION 
From the preparative point of view, the methods em- 
ployed for the coating of the various sorbents form a 
satisfying set of techniques which can all be scaled up 
for industrial production. The CA-coated activated 
charcoal is already manufactured by Organon Tek- 
nika for use in the Hemopur 260 hemoperfusion car- 
tridge.g The completeness of the coatings and the 
methods used to investigate this have been published 
previously." The crosslinking of agarose capsules is 
a major improvement because the sterilization prob- 
lem has been solved since autoclaving at 122°C is pos- 
sible. In addition the mechanical strength is increased 
by a factor of 4. This implies that the risk of release 
of microparticles, generated by mechanical causes, is 
greatly reduced.12 
The conditions of the in vitro adsorption rate ex- 
periments are directly comparable to the clinical sit- 
uation, since both the recirculating volume and the 
amount of sorbent were equally adapted by scaling 
down normal hemoperfusion conditions by a factor of 
40. The flow rate of 34 ml/min gives rise to the same 
linear flow velocity (in m/s) as is obtained with a flow 
rate of 250 mllmin using the Hemopur 260 column, 
thus operating at the same hydrodynamic conditions. 
This is important as flow rate can influence the ad- 
sorption rate (Fig. 7). 
The adsorption kinetic theory presented in this 
paper describes the process of adsorption as measured 
in our recirculation system with remarkable accuracy. 
As can be observed from Equations 2, 5 ,  and 7, the 
theory predicts an inverse proportionality between the 
radius of the sorbent particles and the appropriate 
rate constant R',  R ,  or K. Figure 6 shows that this 
prediction turns out to be correct. Furthermore it is 
predicted that, in the case of film diffusion limitation, 
the rate constants R' and R are inversely proportional 
to  the "thickness" 6 of the stagnant fluid film. Since 
6 is inversely proportional to  the linear flow ~eloc i ty , '~  
the rate constants should be proportional to  the flow 
rate. Because 6 does not appear in the formulation of 
K (Eq. 7), no influence of flow rate is predicted in the 
pore diffusion limitation mechanism. This turns out 
to be correct as well, as can be concluded from Figure 
7. 
In general, film diffusion limitation is the slowest 
process. It can be compensated for by increasing the 
flow rate, until pore diffusion limitation becomes the 
rate-limiting process. With Amberlite XAD-4, only 
film diffusion limitation was observed (Table I), with 
the exception of the adsorption of methyl orange onto 
agarose capsules. Therefore only minimal effects of 
the coating on the adsorption rate of low molecular 
weight compounds have been observed. Middle molec- 
ular weight compounds (from 1000 daltons) show re- 
duced adsorption rates. This is probably caused by 
concentration polarization. Upon grinding the resin 
and encapsulation in agarose, the hydrodynamic di- 
ameter increases when compared to the native resin, 
while the sorbent content reduces by a factor of 3. 
Therefore both constants R and S decrease. This re- 
sults in a decreased adsorption rate when agarose cap- 
sules are compared on the base of volume. From Fig- 
ure 4, it can be concluded that grinding of Amberlite 
XAD-4 to a fine powder and encapsulation in agarose 
offers no advantages with regard to  adsorption kinet- 
ics, but merely a disadvantage because larger amounts 
of capsules are required to obtain the same capacity. 
Therefore larger columns are also needed. 
A completely different situation is encountered in 
the adsorption onto activated charcoal. With the ex- 
ception of methyl orange, all compounds studied showed 
a pore diffusion-limited adsorption rate onto the 
granular charcoal (Table 11). The reduction in adsorp- 
tion (Q3h/Q3h,native) caused by the CA coating is more 
pronounced, although not dramatically, in the low 
molecular weight region when compared to CA-coated 
XAD-4, this notwithstanding the fact that the latter 
coating is 100 times as thick (3 nm for charcoal versus 
400 nm for XAD-4). Grinding of the charcoal, thus 
offering shorter diffusion routes through the charcoal, 
results in an increase in adsorption rate, especially 
when the same amounts of sorbent are compared. In 
several cases this is accompanied by a change in 
mechanism to film diffusion limitation (Table 11). It 
is concluded that grinding of activated charcoal to  a 
powder and encapsulation in agarose offers advan- 
tages with regard to adsorption kinetics. This advan- 
tage will be even more pronounced when the flow rate 
in clinical use can be increased to 500 ml/min as was 
proposed by Brunner." The compounds used in this 
adsorption study are only model compounds. No sig- 
nificant differences in adsorption rate were measured 
for the adsorption of amino acids, bile acids, fatty 
acids, and octopamine onto coated and uncoated acti- 
vated charcoal and Amberlite XAD-4.'.'' 
Coating with CA markedly improves the blood 
compatibility of activated charcoal and XAD-4, with 
both heparin and citrate as anticoagulant. Encapsu- 
lation in agarose tends to show an improvement even 
when activated charcoal is encapsulated, but not when 
XAD-4 or cation exchange resin is encapsulated. The 
number of experiments however is too small to draw 
final conclusions from the agarose measurements as 
yet. Even coating with PLE appears to  be an improve- 
ment compared to CA when citrated blood is used. 
With heparin the sequence is reversed, a phenomenon 
which is difficult to explain, In agreement with the 
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results published by several authors,16 use of citrate 
as anticoagulant resulted in a reduced loss of throm- 
bocytes as compared to  heparin. The thrombocyte 
losses in these in vitro experiments are naturally very 
high as the conditions of experiment are quite drastic. 
The amount of sorbent is five times the amount used 
in normal clinical conditions. The blood is recirculated 
approximatrely 75 times through the column in every 
experiment. 
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